Select Publications
Journal articles
2018, 'Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy', Journal of Clinical Nursing, 27, pp. 2673 - 2683, http://dx.doi.org/10.1111/jocn.14367
,2018, 'Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study', Journal of Viral Hepatitis, 25, pp. 457 - 464, http://dx.doi.org/10.1111/jvh.12801
,2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063
,2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, 23, pp. 425 - 433, http://dx.doi.org/10.3851/IMP3219
,2018, 'General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C', Internal Medicine Journal, 48, pp. 105 - 106, http://dx.doi.org/10.1111/imj.13662
,2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x
,2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011
,2017, 'Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016)', JOURNAL OF CLINICAL NURSING, 26, pp. 3751 - 3751, http://dx.doi.org/10.1111/jocn.14074
,2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161
,2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087
,2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168
,2017, 'Soluble CD147 has an altered expression profile with liver disease progression and in different ethnicities', JOURNAL OF HEPATOLOGY, 66, pp. S658 - S658, http://dx.doi.org/10.1016/S0168-8278(17)31783-X
,2017, 'P13 Call: community assessment and liver liaison, a liver clinic provided to homeless men in their community', Journal of Virus Eradication, 3, pp. 16 - 17, http://dx.doi.org/10.1016/s2055-6640(20)30754-8
,2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
,2016, 'Elevated serum ferritin: Identifying iron overload', Medicine Today, 7, pp. 51 - 52
,2015, 'Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study', Journal of Diabetes, 7, pp. 809 - 819, http://dx.doi.org/10.1111/1753-0407.12237
,2015, 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)', ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 42, pp. 829 - 844, http://dx.doi.org/10.1111/apt.13342
,2015, 'Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial', LANCET ONCOLOGY, 16, pp. 859 - 870, http://dx.doi.org/10.1016/S1470-2045(15)00050-9
,2015, 'Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity', Diabetes Research and Clinical Practice, 108, pp. 466 - 472, http://dx.doi.org/10.1016/j.diabres.2015.02.024
,2015, 'HCV‐infected patients need access now to new direct‐acting antiviral agents to avert liver‐related deaths', The Medical Journal of Australia, 202, pp. 479 - 479, http://dx.doi.org/10.5694/mja15.00165
,2014, 'A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection', Journal of Hepatology, 61, pp. 1238 - 1246, http://dx.doi.org/10.1016/j.jhep.2014.07.022
,2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Historical epidemiology of hepatitis C virus (HCV) in selected countries', Journal of viral hepatitis, 21, pp. 5 - 33, http://dx.doi.org/10.1111/jvh.12247
,2014, 'Strategies to manage hepatitis C virus (HCV) disease burden', Journal of viral hepatitis, 21, pp. 60 - 89, http://dx.doi.org/10.1111/jvh.12249
,2014, 'The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm', Journal of viral hepatitis, 21, pp. 34 - 59, http://dx.doi.org/10.1111/jvh.12248
,2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, http://dx.doi.org/10.1111/liv.12473
,2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424
,2014, 'Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1 - 9, http://dx.doi.org/10.1111/jgh.12677
,2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462
,2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543
,2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7
,2012, 'Barriers Faced by Migrants in Accessing Healthcare for Viral Hepatitis Infection.', Internal Medicine Journal, 42, pp. 491 - 496, http://dx.doi.org/10.1111/j.1445-5994.2011.02647.x
,2012, 'General practitioners' knowledge and management of viral hepatitis in the migrant population.', Internal Medicine Journal, 42, pp. 497 - 504, http://dx.doi.org/10.1111/j.1445-5994.2011.02440.x
,2011, 'Standard Therapy for Genotypes 2/3', , pp. 90 - 96, http://dx.doi.org/10.1002/9781444346343.ch12
,2011, 'Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C', Journal of Viral Hepatitis, 18, pp. 331 - 337, http://dx.doi.org/10.1111/j.1365-2893.2010.01310.x
,2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1', GASTROENTEROLOGY, 139, pp. 1257 - 1266, http://dx.doi.org/10.1053/j.gastro.2010.06.066
,2010, 'Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-alpha in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3', GASTROENTEROLOGY, 139, pp. 1267 - +, http://dx.doi.org/10.1053/j.gastro.2010.06.062
,2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A284 - A284, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A285 - A285, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes', Journal of Gastroenterology and Hepatology (Australia), 24, pp. 998 - 1001, http://dx.doi.org/10.1111/j.1440-1746.2009.05841.x
,2009, 'Cytokines and liver injury in chronic HCV genotype 4 infection', Journal of Gastroenterology and Hepatology, 24, pp. 332 - 335
,2008, 'Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase', Journal of Viral Hepatitis, 15, pp. 571 - 577, http://dx.doi.org/10.1111/j.1365-2893.2008.00980.x
,2008, 'Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?', Hepatology, 47, pp. 1418 - 1421, http://dx.doi.org/10.1002/hep.22300
,2008, 'A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection', Hepatology, 48, pp. 374 - 384, http://dx.doi.org/10.1002/hep.22387
,2008, 'Factors influencing the participation of gastroenterologists and hepatologists in clinical research', BMC Health Services Research, 8, pp. 1 - 11
,2008, 'Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C', Internal Medicine Journal, 38, pp. 207 - 210, http://dx.doi.org/10.1111/j.1445-5994.2007.01625.x
,2008, 'Treatment responses in Asians and Caucasians with chronic hepatitis C infection', World Journal of Gastroenterology, 14, pp. 3416 - 3420
,2007, 'Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection', Journal of Translational Medicine, 5, http://dx.doi.org/10.1186/1479-5876-5-33
,